This content is machine translated Guselkumab Study success: application for admission to PsoA submitted New Phase III data from the DISCOVER-1 and DISCOVER-2 studies show improvement in joint and skin symptoms of psoriatic arthritis at week 52, and an indication expansion of guselkumab is…
View Post 4 min This content is machine translated Dermatomyositis Auto-antibodies are diagnostically and prognostically significant In addition to history, clinical examination and imaging, the determination of antibodies is an important method for the diagnosis of dermatomyositis as well as a prognostic clue. Several specific antibodies…
View Post 5 min This content is machine translated Systemic lupus erythematosus (SLE) Besides Belimumab, other biologics soon available for the treatment of SLE? The therapeutic options available today allow the choice of an individualized therapeutic strategy. In addition to covventional immunosuppressants, biologics are becoming increasingly important. Belimumab has been approved as an add-on…
View Post 3 min This content is machine translated Rheumatoid arthritis Using “windows of opportunity” for disease-modifying therapy. Diagnosis at an early stage of the disease is a prerequisite to take advantage of the time window for optimally effective disease-modifying therapy (DMARD). This not only enables a reduction…
View Post 3 min This content is machine translated Pain Medicine Challenges and possibilities of therapy with cannabinoids Cannabinoids are becoming increasingly important in medicine. First used to treat nausea and loss of appetite in tumor and HIV patients, they are increasingly being used in certain nephropathies, multiple…
View Post 6 min This content is machine translated RA therapy Let’s talk about JAKs The treatment of rheumatoid arthritis (RA) has made great progress over the past 20 years. This relates both to the range of drugs available and to developments in terms of…
View Post 1 min This content is machine translated Systemic lupus erythematosus (SLE) Continue basic therapy during corona pandemic? In general, for SLE, it is recommended to continue therapies with drugs that suppress the immune system despite the coronavirus pandemic. Even in immunocompromised patients, the majority of infections appear…
View Post 8 min This content is machine translated Systemic lupus erythematosus New possibilities for SLE therapy The core of the previous classification criteria for systemic lupus erythematosus (SLE) originated in 1982 and were only slightly modified in 1997. It is therefore high time to address the…
View Post 4 min This content is machine translated Naproxen vs. colchicine in arthritis urica What better gout? Non-steroidal anti-inflammatory drugs (NSAIDs) are effective treatment options for gout attacks, but are often associated with side effects. Lower doses of colchicine are as effective and better tolerated than high…
View Post 5 min This content is machine translated Inflammatory rheumatic joint diseases Broad spectrum of differential diagnoses A timely correct diagnosis can positively influence the course and treatment options. Auto-antibodies and other serological parameters are diagnostically valuable, but do not have high significance when considered in isolation.…
View Post 3 min This content is machine translated Rheumatic diseases How do antirheumatic drugs correlate with COVID-19 courses? Whether the use of immunosuppressants increases the risk of a severe course in SARS-CoV-2 infection is as yet unclear. A study published in advance of the European Congress of Rheumatology…
